Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT.

We observed no difference in efficacy and safety of early combined immunosuppression compared to conventional management in older and younger patients. Early combined immunosuppression may be considered as a treatment option in selected older patients with Crohn's disease with suboptimal disease control. Clinical Trial Identifier: NCT01030809.